Inventor
BROEKER JOACHIM
AT10 patents
Patents
10 patentsUS10144739B2Dec 4, 2018
Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
BOEHRINGER INGELHEIM INT9 citations82
US10246467B2Apr 2, 2019
Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-p53 inhibitors
BOEHRINGER INGELHEIM INT9 citations81
US10919913B2Feb 16, 2021
Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-p53 inhibitors
BOEHRINGER INGELHEIM INT2 citations70
USRE50594ESep 23, 2025
Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
BOEHRINGER INGELHEIM INT0 citations60
US12312363B2May 27, 2025
Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-p53 inhibitors
BOEHRINGER INGELHEIM INT0 citations60
US10882866B1Jan 5, 2021
Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
BOEHRINGER INGELHEIM INT0 citations60
US12545670B2Feb 10, 2026
Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer
BOEHRINGER INGELHEIM INT0 citations56
US11945812B2Apr 2, 2024
Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer
BOEHRINGER INGELHEIM INT0 citations56
US10717742B2Jul 21, 2020
Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
BOEHRINGER INGELHEIM INT0 citations49
US12060367B2Aug 13, 2024
Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer
BOEHRINGER INGELHEIM INT0 citations46